跳至主要内容

FAQ-Strategies to avoid oil precipitation during crystallization of small molecule compounds

 


The phenomenon of oil precipitation is called “oiling”, also known as liquid-liquid demixing or liquid-liquid phase separation (LLPS).  The solute-enriched phase produced by the oil separation process is called the oil phase, and the solute-rich phase is called the water phase.  The frequency of oil separation in the test depends on the specific test conditions and the material system involved.  Oil precipitation may be common under certain substances or reaction conditions, including: low melting point, relatively large relative molecular weight, polypeptides, cyclic lipopeptides; molecular species containing flexible structures, such as long carbon chains that are easy to rotate; and sugars.

During the test, the phenomenon of oil separation may lead to inaccurate analysis results and affect the normal operation of the test such as the reaction rate slows down, product recovery is difficult, equipment is blocked, and other problems.  In order to avoid or solve the phenomenon of oil separation, we can control the supersaturation, add seed crystals, remove impurities, remove solvent residues, control the temperature, replace the solvent system, adjust the pH value, control the operating conditions such as stirring speed to reduce the possibility of oil precipitation.

Dr. Zhonghua Zhang, Assistant Director of Medicilon’s Processing Department, was a guest in the Medicilon’s Cloud Lecture Hall and explained the strategies to avoid oil precipitation during the crystallization process of small molecule compounds, and explained the oil precipitation solution through practical cases. Medicilon has consolidated the frequently asked questions during the live broadcast for everyone, hoping to further help and reduce the worries about oil precipitation/crystallization.

Q: What does slurry conversion mean? Is it necessary to keep stirring during the slurry aging process?

A:Slurry conversion is a maturation process.  As the name suggests, slurry does not have a dissolved system and is in a suspended state.  The sample is added to a solvent to form a suspension.  When the suspension is stirred for a long time, it will be assumed to be metastable crystalline or amorphous like Ostwald’s rule.  It is then possible to slowly convert to a lower energy crystalline form, and this is maturation.

The slurry needs to be stirred continuously during the maturation process. Stirring can accelerate the disturbance. Otherwise, the seed crystal will remain in one position after being added and it will be difficult to induce it.  Stirring is very important for slurry maturation, and both magnetic stirring and mechanical stirring are acceptable.

Pharmaceutical Research

Pharmaceutical research mainly includes APIs and preparation development, quality control and stability study, etc. Medicilon has a wide experience in pharmaceutical research services such as green enzyme chemistry, API quality research, insoluble innovative drug technology, and high-quality preparations.

Click for more

Q: During the antisolvent crystallization process, when adding the seed crystal, the seed crystal also turns into oil. How to deal with it?

A: Let me give you an example. If this situation occurs when adding seed crystals, you can choose to increase the amount of seed crystals, or you need to pay attention to the order of adding materials.  For example, if the previous crystallization method is to add the antisolvent to the good solvent, then you can consider adding the seed crystal to the poor solvent to form a suspension, and then slowly add the desired crystallized sample dropwise to the solution with the seed crystal. In the solution, be careful to add the material slowly, as this may induce it.

Q: How to determine crystal purity and how to determine whether it is mixed crystal?

A: This is the most standard way to determine by simulating powder diagrams based on single crystal data.  If it is difficult to prepare single crystals of some compounds, you can try multiple batches of tests, such as using different crystallization methods.  It turns out that all the XRPD, DSC and TGA data of the sample obtained are consistent, and the XRPD patterns are consistent. At this time, you can basically determine that it is a single crystal form.  The XRPD spectrum of the mixture is the superposition of the XRPD spectra of each component, so the most likely case of multi-peak XRPD is that other crystal forms of the compound are mixed in.  Assuming that A and B are mixed crystals, the characteristic peaks of both crystal forms may appear.  Because it has fingerprint properties, if you can observe the characteristics of A and B through the XRPD pattern, you can determine that it is a mixed crystal.  If the purity of the crystal form is to be determined, quantitative analysis method development is required.  It is difficult to tell the proportion of crystal forms just by looking at an XRPD chart.

Q: How are crystal forms with similar structures removed from products?

A: The amount of seed crystals used for induction is very small. After the foreign matter is added, a batch of samples is induced.  Next, the induced products are used as seed crystals to induce the next batch.  Then, the added foreign matter will be gradually diluted and gradually removed.

Q: What should be done if solids are obviously suspended at -10 degrees and turn into mucus during subsequent filtration?

A: It looks like a solid, but in fact it is not a real solid (crystal).  It is actually a kind of gel. When you suck it up with a disposable straw, you will find that it absorbs moisture immediately and then melts.  For solutions, you can refer to the solutions in the live broadcast, or you can try to lower the temperature before investigating, or you can also consider extending the stirring time.

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...